College of Pharmacy, Yeungnam University , Dae-Dong, Gyongsan , South Korea .
Drug Dev Ind Pharm. 2014 Feb;40(2):172-7. doi: 10.3109/03639045.2012.752501. Epub 2013 Apr 19.
A novel flurbiprofen-loaded nanoemulsion which gave uniform emulsion droplets with a narrow size distribution was previously reported to be prepared using membrane emulsification method. The purpose of this study is to develop a novel flurbiprofen-loaded nanoparticle with a narrow size distribution and improved bioavailability.
The nanoparticle was prepared by solidifying nanoemulsion using sucrose as a carrier via spray drying method. Its physicochemical properties were investigated using SEM, DSC and PXRD. Furthermore, dissolution and bioavailability in rats were evaluated compared to a flurbiprofen-loaded commercial product.
The flurbiprofen-loaded nanoparticles with flurbiprofen/sucrose/surfactant mixture (1/20/2, weight ratio) gave good solidification and no stickiness. They associated with about 70,000-fold improved drug solubility and had a mean size of about 300 nm with a narrow size distribution. Flurbiprofen was present in a changed amorphous state in these nanoparticles. Moreover, the nanoparticles gave significantly shorter Tmax, and higher AUC and Cmax of the drug compared to the commercial product (p < 0.05). In particular, they showed about nine-fold higher AUC of the drug than did the commercial product.
These flurbiprofen-loaded nanoparticles prepared with sucrose by the membrane emulsification and spray drying method would be a potential candidate for orally delivering poorly water-soluble flurbiprofen with enhanced bioavailability.
先前报道了一种新型氟比洛芬负载纳米乳,其采用膜乳化法制备,可得到粒径分布均匀的乳滴。本研究旨在开发一种新型氟比洛芬载纳米粒,具有较窄的粒径分布和提高的生物利用度。
采用喷雾干燥法,以蔗糖为载体,固化纳米乳制备纳米粒。采用 SEM、DSC 和 PXRD 研究其理化性质。并与氟比洛芬负载的商业产品进行比较,考察其在大鼠体内的溶解和生物利用度。
氟比洛芬/蔗糖/表面活性剂混合物(1/20/2,重量比)负载的纳米粒具有良好的固化效果,无粘性。它们使药物的溶解度提高了约 70000 倍,平均粒径约为 300nm,粒径分布较窄。氟比洛芬在这些纳米粒中呈无定形状态。此外,与商业产品相比,纳米粒使药物的 Tmax 显著缩短,AUC 和 Cmax 显著升高(p<0.05)。特别是,与商业产品相比,它们的药物 AUC 提高了约 9 倍。
采用膜乳化和喷雾干燥法用蔗糖制备的氟比洛芬载纳米粒,可能是一种具有增强生物利用度的口服传递难溶性氟比洛芬的潜在候选药物。